Month: August 2021

Categories
Pharmaceutical

Rising Prevalence of Osteoporosis among Women Is Expected to Trigger the Demand for Estrogen Replacement Therapy

The Demand for hormone replacement therapy is foreseen to expand at a significant pace with sales of hormone replacement therapy products crossing US$ 12,000 Mn by 2019 end.

Rising incidences of osteoporosis fractures coupled with growing menopause rates among women have remained instrumental in driving the demand for hormone replacement therapy. Fact.MR envisages that the demand for hormone replacement therapy is projected to expand at a CAGR of 6.0% in terms of value throughout the period of forecast, 2018-2028.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=2224

Disorders associated with hormonal imbalance continue to influence the use of hormone replacement therapy worldwide. Hormone replacement therapy demand is further pushed with macroeconomic aspects such as growing geriatric population and significant increase in healthcare expenditure worldwide. Growing age directly impacts secretion of hormones such as progesterone and estrogen in women, which is expected to trigger the use of estrogen hormone replacement therapy.

Expanding range of menopausal window (45-55 years) coupled with growing number of postmenopausal patients are few of the key factors influencing the growth of the hormone replacement therapy market.

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=2224

According to the report, the demand for estrogen hormone replacement therapy is expected to grow on the back of growing menopausal rate worldwide. The sales of estrogen hormone replacement therapy are likely to surpass US$ 18,000 Mn by 2028, higher than those of other hormone replacement therapy products including thyroid and growth hormone related hormone replacement therapy products, says the report.

Sales of hormone replacement therapy products through hospital pharmacies and retail pharmacies are likely to be on an upswing with developers of hormone replacement therapy products relying on these channels than online selling. Retail pharmacies are expected to remain an attractive distribution channel for hormone replacement therapy products, with sales accounting for a larger revenue share of the overall hormone replacement therapy market. The sales of hormone replacement therapy through clinics are projected to grow at a steady during the 2018-2028 timeline.

hormone replacement therapy market 0

Full Access of This Report Is Available At
https://www.factmr.com/checkout/2224

The hormone replacement therapy market is expected to remain influenced by increasing government support apropos to women’s health. Governments and non-profit organizations of various countries are spreading awareness regarding hormone replacement therapy along with providing free treatments to lower and middle class people. Regulatory authorities such as FDA are also contributing to the cause of supporting women’s health by launching initiatives such as Take Time To Care (TTTC) programs. This aspect is likely to support the growth of the hormone replacement therapy market in the coming years.

Sales of hormone replacement therapy products are likely to remain concentrated among developed countries of North America and Europe. Tug-of-war between North America and Europe apropos to demand for hormone replacement therapy has been witnessed since the past couple of years, with the latter gaining tempo over the former, says the report.

Stakeholders in the hormone replacement therapy can find attractive opportunities in developed countries in North America, particularly the United States. According to the American Congress of Obstetricians and Gynecologists, around 6,000 women reach menopause every day, reaching a count of over 2 million annually. This has translated into significant adoption of hormone replacement therapy in the country. The demand for hormone replacement therapy in the US is also accompanied by higher GDP per capita, triggering high healthcare expenditure.

For More Insights
https://www.biospace.com/article/increasing-kidney-disorder-prevalence-coupled-with-unhealthy-lifestyle-habits-are-driving-growth-of-global-bartter-syndrome-treatment-market

The report also foresees that the hormone replacement therapy market in Asia Pacific excluding Japan (APEJ) region is poised to expand at a relatively higher pace as compared to other regions. According to the report, the APEJ hormone replacement therapy market is projected to expand at a stellar pace of 7.2% during the assessment period. This growth can be attributed to increasing population coupled with higher life expectancy in emerging economies such as India and China. Against this backdrop, stakeholders in hormone replacement therapy market can expect optimistic growth in the region in the years to follow, leveraging its lucrativeness from an investment standpoint.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

 

Categories
Pharmaceutical

Demand for Powered ENT Surgical System Devices Is Projected to Grow at 6.4% CAGR through 2028

ENT surgical devices market is expected to surpass US$ 2,500 million in 2019, according to a new study by Fact.MR. The ENT surgical devices market witnessed a steady progress and grew at 6.6% y-o-y in 2018. Overall growth of the ENT surgical devices market can be attributed to,

  • Technological advancements enhancing ENT procedure efficiency and outcome
  • Reimbursement policies in favor of ENT surgeries
  • Product developments accommodating demand trend such as minimal invasion

The medical technology industry has shifted from a traditional marketing model to a care delivery model. Following the new business approach, Tier 1 and Tier 2 players portray hegemony in the market and continue to introduce disruptive technology innovations in ENT surgical devices.

Click Here To get a Sample Report (Including Full TOC, Table & Figures):-
https://www.factmr.com/connectus/sample?flag=S&rep_id=2454

The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders and emerging players associated with Dual Interface ENT Surgical Devices Market. The study also provides the dynamics that are responsible for influencing the future status of the market over the forecast period.

Key Segments Covered

  • Product Type
    • ENT Surgical Laser Devices
    • ENT Surgical Hand Instruments
    • Powered ENT Surgical System Devices
    • Radiofrequency ENT Electrosurgical Devices
    • ENT Surgery Workstations
    • ENT Surgical Navigation Systems
    • ENT Visualization Systems
    • ENT Surgical Microscopes
  • End User
    • ENT Surgical Devices for Hospitals
    • ENT Surgical Devices for Ambulatory Surgical Centers
    • ENT Surgical Devices for ENT Clinics
  • Modality
    • Hand-held ENT Surgical Devices
    • Portable ENT Surgical Devices
    • Fixed ENT Surgical Devices

Connect To an Expert:-https://www.factmr.com/connectus/sample?flag=AE&rep_id=2454

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

To Get All-In Insights On the Regional Landscape of The Report Market, Buy Now:-  https://www.factmr.com/checkout/2454

Fixed ENT Surgical Devices to Hold Over 37% Revenue Share in 2019

Based on modality, three types of devices are present – handheld, portable and fixed. Owing to the popularity of fixed devices, Fact.MR estimates that these devices will continue to account for a higher market share. On the other hand, handheld devices are estimated to account for the second largest revenue in the ENT surgical devices market and will register faster expansion in the coming years.

According to the study, North America dominates the ENT surgical devices market and will account for over one forth revenue share in 2019. The market growth in North America is favored by favorable healthcare reimbursement coverage. In addition, presence of industry leaders in the regions contributes to the higher market revenues.

The study finds that Europe follows North America with the second largest revenues. Europe and APEJ collectively held over half the revenues in 2018. While Europe presents an established market, improving healthcare infrastructure and economic standards in APEJ can be attributed to the growth scenario of the ENT surgical devices market in the coming years.

Some important questions that the ENT Surgical Devices Market report tries to answer exhaustively are: 

  • Key strategic moves by various players in the ENT Surgical Devices Market in recent years with respect to product launches, deals and tie-ups, and mergers and acquisitions, and divestment of shares
  • Which strategies will enable top players in the ENT Surgical Devices Market to expand their geographic footprints
  • Which new business models are expected to change the course of growth of key regional markets in near future
  • Which technologies will witness most attractive research investments and what will be the key sources of funding for startups and new entrants
  • Which products segments have in recent years have seen new, lucrative application areas

Need More Information about Report Methodology? Click here:-https://www.factmr.com/connectus/sample?flag=RM&rep_id=2454

The research attempts to answer many queries such as:

  1. What needs are the leading manufacturers trying to meet by the forecast period 2025?
  2. What challenges will vendors running the ENT Surgical Devices market go through?
  3. What aspects do the consumers look up while buying ENT Surgical Devices?
  4. How will the competitive framework look like between the foreseeable period 2018 to 2025?
  5. At present, who is buying your product or service globally?
  6. Who are your primary contenders?
  7. What will be the cost of the products and facilities across various regions?
  8. What are the trends affecting the performance of the ENT Surgical Devices market?

Read More Trending Reports of Fact.MR: –http://www.globenewswire.com/en/news-release/2018/04/30/1489775/0/en/6-Key-Takeaways-from-Fact-MR-s-Report-on-Drip-Coffee-Machine-Market-for-Forecast-Period-2017-2026.html

Benefits of Fact.MR Study

Fact.MR has gradually established itself as one of the leading market research companies across the globe. Our unique, methodical, and up-to-date approach towards creating high-quality market reports ensures the reports include relevant market insights. Further, our team of analysts leaves no stone unturned while curating market reports in accord with the requirement of our clients.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Minimally Invasive Surgery Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031

Sterile Vials Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031

Radiation Proctitis Treatment Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Demand for Lung Cancer Diagnostics CA Test Is Expected to Reach US$ 889.3 Mn by the End of 2022

Impact of Covid-19 on Healthcare Industry

With the pandemic plaguing maximum countries across the globe, healthcare industry is witnessing its fair share of ‘ups and downs’. The COVID-19 has placed an enormous strain on the healthcare sector’s workforce, facilities and infrastructure. Despite the endless pressure, healthcare sector is growing at a moderate pace due to the improvement in infrastructure and advancement in technology, healthcare sector is delivering a healthy performance.

According to a recent report by Fact.MR, the global demand for lung cancer diagnostics is anticipated to register 7.3% CAGR throughout the forecast period 2017 to 2022.

Growth of the global lung cancer diagnostics market is mainly attributed to surging developments in the lung cancer-specific biomarkers. Diagnostic tools, such as these, will facilitate personalized treatment approach for lung malignancies.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=49

Numerous biomarkers are in the research pipeline. Epigenomics AG has launched a new test which is based on blood by utilizing DNA methylation biomarkers, and their developments are in process. Initial results of these tests have guaranteed early diagnosis of lung cancer. These incidences are most likely to increase demand for diagnosis of lung cancer across the globe.

10 Key Takeaways from Fact.MR’s Report on the Global Lung Cancer Diagnostics Market

  1. North America is expected to remain dominant in the global lung cancer diagnostics market, with revenues expected to surpass US$ 1,000 Mn by 2022-end.
  2. Europe will continue to be the second most lucrative region for growth of the market, expanding at a high single-digit CAGR through 2022.
  3. CA tests will remain the largest adopted tests for diagnosis of lung cancer. Revenue from CA tests is expected to reach US$ 889.3 Mn by the end of 2022.
  4. Angiogenesis inhibitor tests will exhibit the fastest expansion in the global market for lung cancer diagnostics, followed by HER 2 tests. However, revenue from ALK tests to diagnose lung cancer is estimated to be low in the market throughout the forecast period.
  5. Hospital-associated labs are expected to remain the most lucrative among end-users in the global lung cancer diagnostics market.
  6. Cancer research institutes are expected to register the fastest growth in the global market for lung cancer diagnostics.
  7. Independent diagnostic laboratories are expected to be the second largest end-users of lung cancer diagnostics throughout the forecast period.
  8. Based on indication, even though non-small cell lung cancer will remain sought-after, small cell-lung cancer will exhibit the fastest growth through 2022. Non-small cell lung cancer will continue to account for the largest revenues during the forecast period.
  9. Revenue from small cell lung cancer will continue to be low in the global lung cancer diagnostics market.

Fact.MR’s report profiles key market players, which include

Illumina, Inc.
Abbott Laboratories
Thermo Fischer Scientific Inc.
QIAGEN N.V.
Quest Diagnostics Incorporated
NeoGenomics Laboratories, Inc.
NanoString Technologies, Inc.
Myriad Genetics, Inc.
Roche Holding AG
Danaher Corporation.

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=49

Global Lung Cancer Diagnostics Market: Segmentation

For clearer understanding of the Lung Cancer Diagnostics Market, analysts have segmented the market. The segmentation has been done on the basis of application, technology, and users. Each segment has been further explained with the help of graphs figures. This breakdown of the market gives the readers an objective view of the global Lung Cancer Diagnostics Market, which is essential to make sound investments.

Market Taxonomy

Test Type End User Indication
CA Test Hospital Associated Labs Non Small-cell Lung Cancer
HER2 Tests Independent Diagnostic Laboratories Small-cell Lung Cancer
ALK Tests Cancer Research Institutes
Angiogenesis Inhibitor Others
EGFR Mutation Tests
KRAS Mutation Tests
Others

A market research study is incomplete without regional analysis, and we are well aware of it. That is why, the report includes a comprehensive and all-inclusive study that solely concentrates on the geographical growth of the global Lung Cancer Diagnostics Market. The study also includes accurate estimations about market growth at the global, regional, and country levels. It empowers you to understand why some regional markets are flourishing while others are seeing a decline in growth. It also allows you to focus on geographies that hold the potential to create lucrative prospects in the near future.

Segmentation:

Test Type

  • CA Test for Lung Cancer Diagnostics
  • HER2 Tests for Lung Cancer Diagnostics
  • ALK Tests for Lung Cancer Diagnostics
  • Angiogenesis Inhibitor for Lung Cancer Diagnostics
  • EGFR Mutation Tests for Lung Cancer Diagnostics
  • KRAS Mutation Tests for Lung Cancer Diagnostics
  • Others

End-User

  • Lung Cancer Diagnostics  for Hospital Associated Labs
  • Lung Cancer Diagnostics for Independent Diagnostic Laboratories
  • Lung Cancer Diagnostics for Cancer Research Institutes
  • Others

Indication

  • Non-Small-cell Lung Cancer Diagnostics
  • Small-cell Lung Cancer Diagnostics

Following Questions Answers Covered in the Report are:

  • How will the global Lung Cancer Diagnostics Market perform during the forecast period? What will be the market size in terms of value and volume?
  • Which segment will drive the global Lung Cancer Diagnostics Market? Which regional market will show extensive growth in the future? What are the reasons?
  • How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
  • What are the key strategies adopted by players to sustain themselves in the global Lung Cancer Diagnostics Market?
  • How will these strategies influence the market growth and competition?

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=49

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

 

Get More Insights –http://www.globenewswire.com/en/news-release/2020/03/17/2001947/0/en/Sales-of-Automotive-Wrap-Films-to-Expand-6X-Between-2019-and-2029-MEA-Poised-to-Turn-Highly-Lucrative-Forecasts-a-New-Fact-MR-Report.html

 

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

The Lung Cancer Diagnostics Market report answers the following queries:

  1. What is the largest share held by key players in the market?
  2. What strategies have proven most advantageous in the Lung Cancer Diagnostics Market?
  3. Which region promises largest opportunity for new investors during the forecast period 2021 to 2031?
  4. What factors will most likely present challenges to growth during the forecast period?
  5. What will be the value of total revenues, and at what CAGR will the growth compound during the forecast period 2021 to 2031?

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Growing Demand from Blood Banks and Transfusion Centers to Boost Sales of Tissue Blood Thawing Systems: Fact.MR

Big data and analytics will drive patient outcomes in a big way, and the coming years will witness a growing emphasis on healthcare service providers in the business of gathering and processing patient health data.

Sales of blood thawing systems are gaining momentum as the requirement for 2-bag, 4-bags, and dry plasma thawers has been increasing. With rising demand from blood banks, transfusion centers, hospitals, and diagnostic laboratories, blood thawing system manufacturers are expected to come across significant growth scope over the coming years.

A new report by Fact.MR offers an exhaustive overview of global industry trends, demand-supply patterns, and other crucial factors related to blood thawing systems during the forecast period of 2021 to 2031. According to the report, leading players are eyeing the regional markets of North America and Europe, while Asia Pacific will also emerge as another highly lucrative market for blood thawing systems over the coming years.

For detailed insights on enhancing your product footprint, request for a sample here- 

https://www.factmr.com/connectus/sample?flag=S&rep_id=5772

Key Takeaways from Market Study

  • High demand for dry plasma thawers likely to be witnessed
  • Blood plasma and RBCs to emerge as leading segments in terms of sample
  • Growing demand from blood banks and transfusion centers to boost sales of blood thawing systems
  • The United States to hold major share of the North American market for blood thawing systems
  • Germany to remain the hotspot in Europe for blood thawing systems
  • China remains the epicenter of the world’s fastest-growing market for blood thawing systems – Asia Pacific
  • India, Japan, the United Kingdom, France, Italy, and Canada to maintain positive industry outlook throughout the forecast period

Market Segmentation

Fact.MR’s research study assesses the global blood thawing system market in terms of product type, capacity, sample, end user, and region. This report presents extensive market dynamics and trends associated with different segments of the market, and their influence on the growth prospects of the market.

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=5772

Product Type
  • Dry Plasma Thawers
  • Wet Plasma Thawers
Capacity
  • 2 Bags
  • 4 Bags
  • 8 Bags
  • Others
Sample
  • Blood Plasma
  • RBCs
  • Platelets
  • Whole Blood
  • Others
End User
  • Blood Banks
  • Transfusion Centers
  • Hospitals & Diagnostic Laboratories
  • Pharmaceutical Companies
  • Others
Region
  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa (MEA)

Key Questions Answered in Report

For comprehensive insights on this market adoption, ask an analyst here- 

https://www.factmr.com/connectus/sample?flag=AE&rep_id=5772

  • Which are the most lucrative markets for blood thawing systems?
  • Which factors will impact the demand for blood thawing systems?
  • How will changing trends impact the strategies of market players?
  • How can market players capture the low-hanging opportunities across regions?
  • Which companies are leading the global blood thawing system market?
  • What are the winning strategies of stakeholders in the blood thawing system landscape?

blood thawing system market

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the market during the forecast period.

Country-specific valuation on demand for blood thawing systems has been offered for each regional market, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value for emerging countries has also been included in the report.

For in-depth competitive analysis, buy now- https://www.factmr.com/checkout/5772

Key Competitve Players

  • Fremon Scientific Inc.
  • Helmer Scientific Inc.
  • Barkey GmbH & Co. KG
  • Boekel Scientific
  • KW Scientific Apparatus Srl
  • Cardinal Health
  • Cytiva
  • Sarstedt AG & Co. KG
  • Thermo Fisher Scientific, Inc.
  • Sartorius AG

For More Insights: 

https://www.biospace.com/article/andersen-tawil-syndrome-market-gains-ground-with-government-incentives-towards-rare-disease-treatments-fact-mr/

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Topical Ocular Drug Delivery Technology Market Business Opportunities, Survey, Growth Analysis And Industry Outlook

It is anticipated that glaucoma cases will surpass 100 million by 2040, while macular degeneration shall reach nearly 200 million by 2020-end. These increasing cases are poised to heighten prospects for ocular drug delivery market in the forecast period (2020-2025).

Immense research and development is occurring in the ocular drug delivery market. Shortages in bioavailability of such drugs is a key growth driver. Studies have shown that micellar formulations and derivative active pharmaceutical ingredients have immense scope for development. Based on these trends, the global ocular drug delivery technology market is poised to register positive growth. The market is anticipated to expand 1.4x by 2025-end.

To remain ‘ahead’ of your competitors, request a sample

https://www.factmr.com/connectus/sample?flag=S&rep_id=4802

A detailed assessment of the global ocular drug delivery technology market’s value chain analysis, business execution, and supply chain analysis across the regional markets has been covered in the report. A list of prominent companies operating in the global ocular drug delivery technology market along with their product portfolio enhances the reliability of this comprehensive research study.

“The global ocular drug delivery technology market is set to burgeon positively. Exhaustive research in development of new drug formulations by leading manufacturers is anticipated to drive the growth forward,” infers a Fact.MR analyst.

Key Takeaways of Global Ocular Drug Delivery Technology Market Study:

  • By technology, topical drug delivery is set to dominate the market, capturing nearly half of the market share. Affordability and introduction of emulsion and suspension forms are attributed as key growth drivers. The topical drugs segment is close behind, expanding 1.4x. Long-term effectiveness and precise drug delivery are important growth drivers.
  • By formulation type, solutions are anticipated to capture the majority share, accounting for more than three-fifths of the global ocular drug delivery technology market. High production volume, high-patient compliance and cost effectiveness are important growth levers.
  • By disease type, macular degeneration is set to dominate the global ocular drug delivery technology market. This is followed by diabetic retinopathy. Each segment is poised to account for more than one-fifth of the market share. Rising prevalence of the diseases is the main driver behind the growth of these segments.
  • By end-user, hospitals are poised to account for a major chunk of the market. This is attributed to availability of trained and qualified personnel and well-equipped healthcare facilities. Moreover, technology integration in hospital systems is also set to brighten growth of the segment.
  • By region, North America shall retain market dominance, attributed to presence of key manufacturers and rising visual impairment cases. A market share of more than half is anticipated for the North American Market. Trailing behind is the Asia-Pacific, anticipated to generate substantial growth opportunities. Advancement of research grants, increasing prevalence of cataract and uveitis and presence of key players shall augment growth. The Asia-Pacific region is set to expand a CAGR of 7.0% in the forecast period.

Speak To Research Analyst For Detailed Insights:

https://www.factmr.com/connectus/sample?flag=AE&rep_id=4802

Global Ocular Drug Delivery Technology Market Segmentation

Fact.MR has studied the global ocular drug delivery technology market with detailed segmentation on the basis of technology type, formulation type, disease type, end-user and region.

Technology Type

Formulation Type

Disease Type

End-user

Region
Topical Solution Glaucoma Hospitals North America
Ocular Inserts:Non-erodibleErodible Suspension Diabetic Retinopathy Ambulatory Surgical Centers Europe
Iontophoresis Emulsion Dry Eye Syndrome Ophthalmic Clinics Asia Pacific
Intraocular Implants:BiodegradableNon-biodegradable Liposomes & Nanoparticles Macular Degeneration Homecare Settings Latin America
In-Situ Gel & Punctal Plugs Ointment Diabetic Macular Edema Middle East & Africa
Others Cataract
Others

“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”

For critical insights on this market, request for methodology here 

https://www.factmr.com/connectus/sample?flag=RM&rep_id=4802

ocular drug delivery technology market size and growth forecast

Global Ocular Drug Delivery Technology Market: Analysis on Market Size Evaluation

The global ocular drug delivery technology market has been analyzed for each market segment, in terms of value (US$ Mn).

Market estimates at global and regional levels for global ocular drug delivery technology market is available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent global ocular drug delivery technology market segments, along with market attractiveness evaluation has been incorporated in the report.

Global Ocular Drug Delivery Technology Market: Inspected Assessment on Regional Segments

Key sections have been elaborated in the global ocular drug delivery technology report, which have helped deliver projection on the regional markets. These chapters include the regional macros (economic and business environment outlook), which are expected to have a momentous influence on the growth of the global ocular drug delivery technology market during the forecast period.

Country-specific valuation on demand for global ocular drug delivery technology has been offered for each regional market, along with the market scope estimate and forecast, price index, and impact analysis of dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value for emerging countries has also been included in the report.

For More Insights: 

https://www.biospace.com/article/porokeratosis-treatment-market-is-surging-on-the-back-rising-focus-on-skincare-fact-mr/

Global Ocular Drug Delivery Technology Market: In-Depth Analysis on Competitive Landscape

The report sheds light on the leading manufacturers of global ocular drug delivery technology products along with their detailed profiles. Essential and up-to-date data information related to the market performers, who are principally engaged in the production of global ocular drug delivery technology products, has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits the report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, such as product portfolio, key strategies along with an all-inclusive SWOT analysis on each player. Company presence is mapped and presented through the matrix for all the prominent players thus providing the readers with actionable insights, which helps in thoughtfully presenting market status, and predicting the competition level in the global ocular drug delivery technology market.

Prominent manufacturers with established market presence in the global ocular drug delivery technology market are

  • Ocular Therapeutix, Inc.
  • Alimera Sciences
  • Allergan plc
  • Valeant Pharmaceuticals International (Bausch Health Company) Inc.
  • Santen Pharmaceutical Co., Ltd.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Proliferative Vitreoretinopathy Market Share, Size & Trend | Industry Analysis Report, Forecast to 2027

With the rise in emphasis on prevention and treatment of proliferative vitreoretinopathy (PVR), a serious ailment that leads to blindness despite repeated treatment, the requirement for vitreoretinal centers has gained importance worldwide. Prevention of PVR development at early stage RRD for preserving visual function in patients has become a primary agenda among medical researchers and clinicians. A recent Fact.MR analysis envisages the proliferative vitreoretinopathy market to reflect a modest 4.0% CAGR during the forecast period (2018-2027).

For detailed insights on enhancing your product footprint, request a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=795

However, establishment of vitreoretinal centers for the provision of advanced ophthalmological procedures is considered impractical, on account of increasing social security costs – a key challenge faced by nations across the globe. In contrast, remarkable advances have been made in medical equipment, and ultra-wide-field scanning laser ophthalmoscope (Optos) is one such advancement. This equipment facilitates the provision of wide-field, noninvasive, and nonmydriatic images, and is being increasingly employed for diagnosis and follow-up of PVR treatment evaluation.

proliferative vitreoretinopathy market

 

Advantages of deep learning in classifying Optus images in RRD have been observed to be slight, however the method has been deemed clinically imperative to achieve higher accuracy. It has been observed that multiple non-linear processing layers in deep learning approach can be leveraged for effective prevention and treatment of proliferative vitreoretinopathy by further studies.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=795

Proliferative Vitreoretinopathy Market: Hospital Pharmacies Continue to Account for Bulk Market Shares

Hospital pharmacies are leading consumers in the pharmacy industry. Policymakers are becoming more aware about importance of offering effective pharmacy services coupled with safe and rational use of medications. In case of proliferative vitreoretinopathy, hospital pharmacies are considered to be radical asset of the modern pharmacy sector. They are vital part of hospitals and clinics, ensuring safe, effective, and economic use of drugs. According to the study, hospital pharmacies will continue to account for bulk shares of the market in the period of forecast.

For comprehensive insights on this market adoption, ask an analyst here – https://www.factmr.com/connectus/sample?flag=AE&rep_id=795

Injectables will remain preferred over other mode of administrations of proliferative vitreoretinopathy management drugs. Treatment of PVR through intravitreal injectables has been considered beneficial as they delivery drugs directly to retina and vitreous. Simplicity of achieving intravitreal injection by doctors is a key factor driving adoption of this method. Subretinal injection has been gaining ground in the treatment of PVR, as it directly affects the resident cells & tissues in subretinal space. However, requirement for highly proficient and stable operators for subretinal injection continues to prevail as a major concern in the healthcare sector.

Proliferative Vitreoretinopathy Market: North America Remains at the Vanguard

North America will continue to be at the forefront of the proliferative vitreoretinopathy market, with approximately two-fifth market revenue share estimated for the region by 2027-end. Favorable government policies and reimbursements provided by the government, along with the occupancy of robust healthcare facilities are key growth determinants for growth of the proliferative vitreoretinopathy market in North America. Additionally, strong penetration of PVR management drugs such as “lornoxicam” has further supported demand for treatment of PVR in the region.

Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2019/04/04/1797163/0/en/Operating-Room-Equipment-Demand-Upheld-by-Increasing-Investments-to-Upgrade-Surgical-Rooms-in-Hospitals.html

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Demand for Automated Breast Ultrasound System Is Set to Record a Value CAGR of 9.3% over the Period of Forecast 2027

The global sales of automated breast ultrasound system will exhibit a volume CAGR of 11.1% during the forecast period (2018-2027), according to a new analytical research study of Fact.MR. The report estimates the global revenue share of the automated breast ultrasound system is set to reach nearly US$ 345 Mn in revenues by 2027-end.

ABUS gaining Competitive Edge over HHUS

Breast cancer has prevailed as most commonly diagnosed cancer type, and has become the second leading cause of mortality among women, according to statistics unveiled by National Breast Cancer Foundation. With growing awareness about breast cancer, number of screening procedures has proliferated, thereby propelling demand for advanced diagnostic and follow-up care technologies such as automated breast ultrasound systems in diagnostic centers and hospitals.

To remain ‘ahead’ of your competitors, request a sample 
https://www.factmr.com/connectus/sample?flag=S&rep_id=585

Facilitated screening of denser breast’s tissues, along with the provision of superior image quality, has offered automated breast ultrasound system (ABUS) a competitive edge over the handheld ultrasound system (HHUS).

As automated breast ultrasound system are approved by the FDA for screening in coordination with mammography, in case of women with denser breast tissues, radiologists are increasingly opting for the technology.

On the back of high quality 3D images offered by ABUS, surgeons are employing the system for pre-operative breast evaluation to identify tumor size and location accurately. However, high cost, and lack of skilled radiologists needed for ABUS have made surgeons to opt for HHUS for pre-operative evaluation.

In addition, the Breast Cancer Now Catalyst Programme encouraged and offered tremendous support to research and development in diagnosis and treatment of breast cancer.  Awareness campaigns on breast cancer are further expected to influence demand for automated breast ultrasound system.

Key Takeaways from Fact.MR’s Report on Automated Breast Ultrasound System Market

  • North America will continue to account for bulk share of the global automated breast ultrasound system market. The U.S. is expected to remain the most lucrative country for the market growth in North America, on account of growing breast cancer prevalence and adoption of advanced screening technologies. Presence of leading market participants, favorable government initiatives, and reimbursement scenario are key growth determinants for automated breast ultrasound system market in North America.
  • Asia-Pacific excluding Japan (APEJ) is estimated to be the fastest expanding market for automated breast ultrasound system through 2027. Revenues from the market in Europe will remain comparatively larger than those from APEJ, and lower than those from North America.
  • On the basis of care type, Hospitals will continue to spearhead the global automated breast ultrasound system market, in terms of revenues. However, revenues from care provided by diagnostic centers will increase at a relatively higher CAGR through 2027.

Speak To Research Analyst For Detailed Insights:
https://www.factmr.com/connectus/sample?flag=AE&rep_id=585

Tested research methodologies employed for developing this report assure that forecasted market size valuations follow a specific growth pattern on the basis of impact of causative factors. This information reveals the dynamics of the global automated breast ultrasound system market across parameter such as

  • Changing regulations on automated breast ultrasound system manufacturing
  • Platforms for cost-effective procurement of raw materials
  • Technological advancements in the working of automated breast ultrasound system
  • Supply chain challenges
  • Impediments for penetrating untapped markets

A cumulative effect of such factors provides the driving force for expansion of the global automated breast ultrasound system market. This study clarifies the impact of growth drivers, sales restraints, market trends and business opportunities with the forecasted findings.

Market Taxonomy

REGION

CARE TYPE
North America Hospitals
Latin America Diagnostic Centers
Europe
Japan
APEJ
MEA

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

For critical insights on this market, request for methodology here 
https://www.factmr.com/connectus/sample?flag=RM&rep_id=585

  • Key market players profiled by Fact.MR’s report

    SonoCine Inc.
  • Koninklijke Philips N.V.
  • Hitachi, Ltd.
  • Siemens AG
  • Delphinus Medical Technologies Inc.
  • GE Healthcare.

Assessing Insights on Expanding Global Footprint

Understanding the lucrativeness of regions is a key challenge for companies in the global automated breast ultrasound system market. Information of country-specific markets and regional undercurrents is being offered to expand the knowledge of automated breast ultrasound system companies. Insights on low-wage countries, regions with favorable industrial regulations and concentered consumer marketplaces can influence the expansion strategies of manufacturers.

The scope of this report is to address major concerns of automated breast ultrasound system manufacturers in terms of product development, sales growth and geographic expansion. Inferences in the report are aimed to help market players take informed steps towards future market direction.

For More Insights: 

https://www.biospace.com/article/ventricular-restoration-systems-market-growth-pursuant-to-successful-feasibility-studies-and-reimbursement-policies/

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Disposable Syringes Market: Quantitative Market Analysis, Current And Future Trends

Around 2 million people get infected with diseases such as HIV and hepatitis each year due to reusable syringes. Disposable syringes prevent the plunger being pulled back after an injection so that it cannot be used again. Thus, use of disposable syringes is gaining wide popularity in hospitals in every part of the world. Expected advantages are ensuring sterility and preventing the spread of infections from patient to patient. Parallel to this, there is also the need to improve disposal facilities at hospital. Across regions, demand for plastic-made syringes and cannulas is high, with a market share of close to 95%.

For detailed insights on enhancing your product footprint, request for a sample here-https://www.factmr.com/connectus/sample?flag=S&rep_id=2007

The COVID-19 pandemic has affected the market quiet significantly. The pandemic has surged demand for syringes, which, in turn, has resulted in shortage of syringes. Currently, with the introduction of vaccines for COVID-19, demand for syringes has surged at an unprecedented rate. Many countries are focusing on carrying out vaccination drives, which is leading to the shortage of syringes. For instance, there is growing fear in Japan that millions of doses of the Pfizer vaccine purchased by the government could get wasted due to shortage of special syringes that maximize the number of shots from each vial. Thus, the pandemic is putting great pressure on manufacturers to ramp up the production of syringes.

“The outbreak of COVID-19 and introduction of vaccines into the market are surging demand for syringes and cannulas,”says a Fact.MR analyst.

syringes and cannulas market region

Key Takeaways from Market Study

  • By product, syringes dominate with a market share of more than 90%, and will further observe a rise in market share during the forecast period.
  • Plastics will dominate the market contributing maximum revenue share.
  • Hospitals will account for bulk of the demand through 2030, with more than 35% of market share.
  • North America holds the highest market share due to initiatives taken up through various exchange programs that spread awareness and distribute clean needles and syringes.
  • The market for syringes and cannulas is projected to progress at a healthy CAGR of more than 6% in China and India.

Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the market are also included in the current study. Depending on potential developments in the syringes and cannulas market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=2007

Key Market Segments

Fact.MR’s study on the syringes and cannulas market offers information divided into four important segments – product, material, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product
  • Syringes
    • Reusable Syringes
    • Disposable Syringes
  • Cannulas
    • Neonatal Cannula
    • Straight Cannula
    • Winged Cannula
    • Cannula with Wings and Ports
    • Cannula with Integrated Stop Cocks
    • Nasal Cannula
Material
  • Plastics
  • Metals
  • Elastomers
  • Glass
End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Cancer Research Centers
  • Nursing Facilities
  • Diagnostic Laboratories
  • Homecare Settings
Region
  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa (MEA)

Get Customization on this Research Report for specific research solutions: https://www.factmr.com/connectus/sample?flag=RC&rep_id=2007

Key Questions Answered in Report

  • Which regions will continue to remain the most profitable regional markets for syringe and cannulas?
  • Which factors will induce a change in the demand for syringe and cannulas during the assessment period?
  • How will changing trends impact the market?
  • How can market players capture the low-hanging opportunities in developed regions?
  • What are the winning strategies of stakeholders to upscale their position in this landscape?
  • What are the restraints that investors need to be aware of and might tackle while investing in the market?
  • What are the developmental trends that will impact the market?
  • How can businesses in the market avail growth the opportunities in developed and emerging sectors?
  • What will be the Impact of the COVID-19 pandemic on the syringes and cannulas market?

Manufacturers Aiming to Strengthen their Position through Acquisitions

Leading manufacturers of medical supplies are focusing on acquisitions and collaborations in order to upsurge their product portfolios and expand their regional presence. This will provide improved patient care while optimizing clinical and economic outcomes.

  • For instance, in January 2019, Cardinal Health announced the acquisition of Mirixa Corporation, a leading organization developing solutions for medication therapy management.
  • In August 2020, B. Braun Medical Inc. and Kerma Medical Product, Inc. announced a collaboration to develop and improve healthcare products and services.

For More Insights https://www.biospace.com/article/absorbable-nonwoven-textiles-demand-driven-by-cross-infection-mitigation-efforts-study/

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Categories
Business

Adoption of Orthopedic Training Is Anticipated to Expand at a CAGR of 5.5% throughout the Forecast Period

COVID-19 Analysis on the Global Medical Education Market

A recent market research report on the Medical Education market published by Fact.MR is an in-depth assessment of the current landscape of the market. Further, the report elaborates on the impact of the COVID-19 on the Medical Education market and provides a thorough understanding of the growth potential of each market segment over the forecast period (2020-2030).

The Demand for medical education is poised to expand at a CAGR of 4.2% during the forecast period (2020-2027). Rising investments in healthcare infrastructure has led to the dissemination of quality medical education around the world. The ongoing novel coronavirus pandemic is also anticipated to significantly influence the market prospects of medical education, attributed to increased usage of online educational fora.

For detailed insights on enhancing your product footprint, request a sample here-  https://www.factmr.com/connectus/sample?flag=S&rep_id=4842

Medical experts, professors, and researchers are relying on the internet to conduct online lectures, upload e-books and audio files, and develop digital games and simulations to help students acquire a practical dimension on healthcare. The pandemic has also motivated key healthcare practitioners to conduct in-depth research on developing drugs and vaccines aimed at eradicating the virus.

“Governments and private institutions across the world are augmenting their funding for providing quality medical education, thus generating significant growth opportunities for the medical education market players. The emergence of online learning has negated the need for attending colleges or universities, further fueling the market growth,” concludes the Fact.MR analyst.

Severe shortages in healthcare across developing and underdeveloped regions have generated credible opportunities for health education providers. Many healthcare institutions have been established to facilitate research and development in these areas in order to create a more robust infrastructure. Furthermore, introduction of niche courses aimed at improving competence of doctors, surgeons, and nurses have also accelerated the scope of medical education in recent years.

For comprehensive insights on this market adoption, ask an analyst here-  https://www.factmr.com/connectus/sample?flag=AE&rep_id=4842

Key Takeaways of the Medical Education Market Study

  • Cardiothoracic training remains highly preferred over other types of training, capturing a nearly one-fifth share of the total market value. High prevalence of lifestyle diseases such as obesity and hypertension has augmented the need for cardiac surgeries, thus stimulating the need for cardiothoracic training.
  • By delivery method, courses continue to account for a majority share of the global market revenue. This is attributable to increasing number of medical courses with sub-specialties.
  • Online and distance modes of training are anticipated to expand the fastest, attributed to mandatory social distancing measures implemented by governments to contain the spread of the coronavirus in 2020.
  • By type of organization, school of medicine is expected to retain its dominance, capturing nearly 40% share of the medical education market. Rising investments in the establishments of medical schools is anticipated to drive the segment’s growth.
  • North America’s medical education market leads the first wave of growth, owing to rising number of enrolments in medical schools and adoption of updated educational frameworks.
  • Market growth prospects remain high in Asia Pacific, attributed to increased adoption of advanced technologies in research and teaching. Asia Pacific’s market value is expected to expand 1.4x during the forecast period.

Need more information about Report Methodology? Click here-https://www.factmr.com/connectus/sample?flag=RM&rep_id=4842

Medical Education Market: Segmentation

Fact.MR has studied the medical education market with detailed segmentation on the basis of delivery method, mode of training, types of training, type of organization and region.

Delivery Method

  • Internet Enduring Materials
  • Courses
  • Regularly Scheduled Series and Other Enduring Materials

Mode of Training

  • On-campus
  • Distance
  • Online

Types of Training

  • Cardiothoracic Training
  • Neurology Training
  • Orthopedic Training
  • Oral and Maxillofacial Training
  • Pediatric Training
  • Radiology Training
  • Laboratory
  • Others

Type of Organization

  • School of Medicine
  • Government/Military Organizations
  • Hospitals
  • Insurance Companies
  • Non-profit Organizations
  • Publishing or Education Companies
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

Tailor-made Courses for Practitioners to Broaden Key Players’ Growth Prospects

The medical education market is highly fragmented, characterized by the presence of a large number of educational providers. Prominent players in the market include, but are not limited to: GE Healthcare, Apollo Hospitals, Olympus Corporation, Stanford University, Johns Hopkins University, Zimmer Biomet Holdings, Inc. and Harvard Medical School. With the presence of such a vast number of players, the medical education market is highly competitive in nature.

Most of these institutions offer specific courses designed to cater to a wide range of healthcare domains. Olympus Corporation, for example, offers the Endoscopic Surgeon Training Program to equip practitioners with the required skill sets to perform endoscopic procedures. Likewise, GE Healthcare offers courses on clinical education, healthcare IT education and product education (clinical and technical). Universities such as the Harvard Medical School offer MD Programs, Combined Degrees and Student Research programs.

medical education market size u$$ mn and growth forecast by mode of training

COVID-19 Impact Analysis

While the entire world has been crippled due to the outbreak of the coronavirus pandemic, a silver lining exists for the medical education market. With nationwide lockdowns and implementation of social distancing measures, healthcare education providers have shifted to the internet to provide education. This has compelled students to effectively utilize technology to complete their courses and acquire their degree or certifications.

Various institutions have designed specific courses to cater to a specific niche area, allowing practitioners to constantly upgrade their skills. Moreover, online portals have experienced a surge in their operations during the pandemic. It is anticipated that online learning shall become the new normal in the aftermath of the pandemic. Also, as the entire healthcare industry is engaged in developing potential cures for the virus, educational institutions are presented with the opportunity of providing tailor-made courses for approaches towards tackling the novel coronavirus. Such trends will thus heighten growth prospects for the medical education market in the future.

For More Insights:  https://www.biospace.com/article/otc-vitamins-and-dietary-supplements-market-gaining-impetus-from-changing-nutrition-requirements-and-self-medication-practices-fact-mr/

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Asia Pacific are Likely to be the Next Key Markets for Investors In the Dental Anesthetics Industry

Witnessing an average Y-o-Y growth of ~5% in the revenues, the global dental anesthetics market is set to reach the US$ 1 billion market, by 2020. Hospitals will remain the cornerstone of the promising growth outlook of dental anesthetics market, according to a recent study of Fact.MR. The report suggests that half of the overall sales of dental anesthetics is accounted by hospital pharmacies, whereas a third of the total dental anesthetics consumption is registered by hospitals.

A Meaningful evolution of the dentistry and healthcare industry in recent years has provided a feasible boost to dental anesthetics, thereby driving developments in the market. Dental consumables industry is growing positively in line with the progressing traction and outgrowing dental anesthetics market, over the recent past. The current growth trend of dental anesthetics market has prominently influenced the increasing number of dental patients across all the regions of the globe, says the report.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=3552

The study opines that although the increasing consumer awareness about oral care and dental treatments will push the growth of dental anesthetics market, the development of oral care and dentistry offers a potential boost to dental anesthetics sales owing to the rising demand from patients for painless operations. Dental anesthetics has steadily gained widespread acceptance as a safe and effective minimally invasive procedure. Healthcare providers around the globe have opted for dental anesthetics as a preferred option while treating a wide range of injuries and disorders.

Dental anesthetics have witnessed several advancements in terms of technology to achieve higher precision and reduce pain during surgeries and operations. There are numerous aspects that have triggered the adoption of dental care thus pushing the growth of the dental anesthetics market. Increasing spending on dental treatments owing to higher disposable income of individuals worldwide coupled with increasing awareness about oral health have positively impacted the global market growth. Fact.MR’s analysis also analyzes how dental tourism is on a constant rise and becoming an increasingly important aspect fueling the growth of dental anesthetics market. Cost-efficient dental procedures and new dental technologies will continue to create new growth opportunities.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=3552

dental anesthetics market analysis

Increasing coverage of commercial insurance and Medicaid represents the powerful tailwind in the entire dental care market. Private health insurance coverage lowers the out of pocket expenses by nearly 80%. For example, the Patient Protection and Affordable Care Act of 2010, is expected to increase the number of individuals with dental benefits by providing consumers with information that would help them better understand the various options and various choices of plans available to them. It will thus create a more organized and competitive market for health insurance by setting common rules regarding the offering and pricing of insurance.

For More Insights: https://www.prnewswire.com/news-releases/blood-collection-tubes-for-liquid-biopsy-sales-set-to-grow-at-12-through-2021-factmr-301245568.html

Market in Europe & APAC Projected for Lucrative Prospects

Fact.MR’s study envisions dental anesthetics market to exhibit significant growth rate during the forecast period. The average per capita spending over oral care and healthcare by North America is slightly more than that of Europe and other regions across the globe, which is likely to boost the growth of dental anesthetics market.

North America’s continued primacy in dental anesthetics market is likely to prevail, followed by Europe. The growth of latter is likely to be driven by mounting R&D investments in dental care space, within countries, such as the UK and Germany. Dental anesthetics are largely being manufactured in Europe, out of which a large percentage is being exported to other regions, according to Fact.MR’s research. Latin America is a potential market for dental products after United States. Brazil market for dental anesthetics is expanding at a constant rate owing to entry of various international players. However, counties like Mexico and Brazil import a range of dental anesthetics from Europe and US on a large scale.

For comprehensive insights on this market adoption, ask an analyst here – https://www.factmr.com/connectus/sample?flag=AE&rep_id=3552

On the other side, Asia Pacific holds lucrative opportunistic potential for the dental anesthetics market, banking on the easy labor availability and relatively lower land costs. Companies are thus strategizing the establishment of their manufacturing bases in Asian economies. Moreover, fast-developing economies, such as China and India, have showcased a notable increase in dental surgeries over the recent past, which continues to trigger increased usage of dental anesthetics in this region.

This Fact.MR study tracks the growth of global dental anesthetics market over a decade-old projection period, 2019-2029.

Why Choose Fact.MR?

  1. Deliver updated information on the current industry trends
  2. Available 24/7 to facilitate clients with unbiased solutions
  3. Embrace digital technologies to offer accurate business ideas
  4. Exhaustive supply chain augmentation analysis
  5. Provide reports strictly according to the requirements of the clients

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Sepsis Diagnostics Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031

Ultrasound Systems Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031

Blood Thawing System Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com